The respiratory device industry in Latin America focuses on addressing various lung-related health issues through innovative technologies. Companies in this field develop tools such as nebulizers, ventilators, and diagnostic equipment that aim to improve patient outcomes. Driven by rising respiratory diseases and an increasing elderly population, market growth is anticipated as healthcare systems modernize. Notable startups and established firms alike are scaling up production and enhancing research capabilities. The industry is witnessing the integration of digital health solutions, fostering new opportunities for patient management and care efficiency.

The list features a mix of venture capital and private equity firms, all focusing on the respiratory device sector. Based in Brazil and Chile, these investors range in size and experience, with funding activity showcasing their commitment to healthcare innovation. Established between 2005 and 2020, these firms have collectively made over 100 investments in 2024, emphasizing their influence in the investment landscape.

Top 7 Respiratory Device Investors in Latin America

1. bossa invest

• Website: bossainvest.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2011
• Headcount: 11-50
• Number of deals in 2024: 56
• LinkedIn: bossainvest

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in the technology sector, and provides capital, strategic guidance, and access to a network of co-investors. Bossa Invest has been involved in several notable transactions, including investments in Empatica, which focuses on health technology, and Vicarious Surgical, which is engaged in surgical robotics. These investments indicate a commitment to supporting health-related innovations, which may encompass respiratory devices, although their primary focus remains broader within the technology landscape.

2. Kptl

• Website: kptl.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2020
• Headcount: 11-50
• Number of deals in 2024: 5
• LinkedIn: inseed-investimentos

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience in the investment landscape, KPTL has made more than 124 investments, focusing on innovative startups across various sectors. Notably, Kptl has invested in companies like Magnamed, which raised $2,606,090 in Series A funding and specializes in respiratory medical devices. Other relevant transactions include Celer Biotecnologia and Tmed, which, while not exclusively focused on respiratory devices, contribute to the healthcare ecosystem. Kptl provides capital and strategic guidance to help these companies grow and succeed in their respective markets, demonstrating their commitment to advancing healthcare technologies.

3. VOX Capital

• Website: voxcapital.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn: vox-capital

VOX Capital is an impact investment firm based in Sao Paulo, Brazil, founded in 2009. They specialize in managing investments that generate positive social and environmental outcomes, focusing on sectors such as healthcare, education, and climate solutions. VOX Capital serves both individual and institutional investors who seek to align their financial goals with their values. Among their notable transactions, they invested in Magnamed, which raised an undisclosed amount in a venture round in 2015, indicating their involvement in the medical device sector. Additionally, they have invested in other healthcare-related companies such as ToLife and ProRadis, which raised significant amounts in Series A funding. These transactions highlight their engagement in the healthcare space, although it is not exclusively focused on respiratory devices.

4. Zentynel Frontier Investments

• Website: zentynel.com
• Type: Venture Capital
• Headquarters: Santiago, Santiago, Chile
• Founded year: 2017
• Headcount: 1-10
• Number of deals in 2024: 4
• LinkedIn: zentynel-frontier-investments

Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in the sector. Notably, Zentynel led a funding round for Respira Labs, a lung-health startup that raised $1 million, highlighting their commitment to respiratory health. Additionally, they have participated in various other biotechnology investments, including companies like Autem Therapeutics and MultiplAI Health, which, while not directly related to respiratory devices, showcase their broader focus on high-growth potential in the biotech field. Their strategic investments aim to support companies in navigating funding challenges and achieving market entry, particularly in areas with significant health impacts.

5. Crescera Capital

• Website: crescera.com
• Type: Private Equity
• Headquarters: Rio De Janeiro, Rio De Janeiro, Brazil
• Founded year: 2008
• Headcount: 11-50
• Number of deals in 2024: 7
• LinkedIn: bozano-investimentos

Crescera Capital is a private equity and venture capital investment firm based in Rio de Janeiro, Brazil, founded in 2008. The firm specializes in providing growth capital and strategic guidance to mid-sized companies across various sectors, including education, technology, and health. Crescera aims to enhance operational performance and prepare companies for market opportunities. Notably, Crescera has made several seed investments in healthcare-related companies, such as Confiance Medical S/A, which raised $793,248 in May 2017. Other investments include Ventrix, Fumajet, and Compass, indicating a focus on innovative solutions within the healthcare space. These transactions highlight Crescera's engagement in the medical sector, which may include respiratory devices, aligning with their investment strategy.

6. Canary

• Website: canary.com.br
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2017
• Headcount: 11-50
• Number of deals in 2024: 23
• LinkedIn: canary-venture-capital

Canary is a venture capital firm based in Sao Paulo, Brazil, founded in 2017. They specialize in early-stage investments across Latin America, supporting entrepreneurs with capital, co-founding assistance, and fostering a strong community of builders. In 2024, they have already made 23 investments, showcasing their active role in the startup ecosystem. Notable transactions include investments in health-related startups such as Mar Saúde, which raised an undisclosed amount in a Seed Round in January 2024, and ISA Saúde, which raised $17 million in a Series A round in August 2022. These investments suggest a focus on the healthcare sector, which may include respiratory devices, although specific transactions in that niche are not highlighted.

7. Monashees

• Website: monashees.com
• Type: Venture Capital
• Headquarters: Sao Paulo, Sao Paulo, Brazil
• Founded year: 2005
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn: monashees-capital

Monashees is a venture capital firm based in Sao Paulo, Brazil, founded in 2005. The firm specializes in investing in technology-based companies across Latin America, providing not only funding but also support in areas such as talent acquisition and fundraising. Monashees has been active in the healthcare sector, with notable investments in companies like Hilab, which raised $10 million in Series B funding in 2020, and Memed, which raised $3 million in Series A funding in 2017. Their recent investment in Livance, a Brazilian ehealth company, further emphasizes their focus on enhancing technology and digitalization within the healthcare sector. These transactions highlight Monashees' engagement in health technology, which may include respiratory devices as part of their broader investment strategy.

Respiratory Device Insights: Key Investors in Latin America

Want to find more investors focusing on the respiratory device industry?

With Inven, you'll also get to know:

• Deal History: Number of deals and their sizes.
• Portfolio: Companies they've invested in.
• Contact data: Key dealmakers, including their emails and phonenumbers.
• ...and much more!